Clinical Laboratories

Where are we going? Where have we been? What is the future? Last month, Tempus purchased Paige AI for $81M, largely in the form of Tempus stock to, as reports mention, for PaigeAI's datasets from 7 million slides, perhaps most of...

The latest from the Proscia blog Emerging biotechs, along with their small and mid-sized CRO counterparts, are establishing themselves as key players advancing the next generation of therapies. So, in line with our mission to rewire...

AiosynQC and IVDR-certified Aiosyn Mitosis Breast are now available through Pathomation’s AI Marketplace, building on their AWAKE project collaboration to transform kidney diagnostics with AI. Antwerp, Belgium, and Nijmegen, Netherlands...

From the Proscia blog: As more laboratories transition from glass slides to images, one sometimes underestimated success factor is laboratory information system (LIS) integration. The LIS continues to underpin the diagnostic workflow, from...

Leica Biosystems: Plug-and-play simplicity meets the demands of modern digital pathology workflows Newcastle, United Kingdom – July 22, 2025 – Leica Biosystems, a global leader in anatomic and digital pathology solutions,...

The latest from the Proscia blog. Tom Gallo is Proscia’s Chief Financial Officer. Arun Ananth is the company’s Chief Commercial Officer.  For years, AI-driven pathology has promised to deliver top- and bottom-line impact for diagnostic...